|
|
Volumn 24, Issue SUPPL. 1, 2012, Pages
|
|
Ginkgo biloba extract EGb 761® in the context of current developments in the diagnosis and treatment of age-related cognitive decline and Alzheimer's disease: A research perspective
a,b
|
|
Author keywords
biomarkers; dementia; dose response; functional imaging; mitochondria; neurotransmission; pathophysiology; prevention; proteasome function; trial design
|
|
Indexed keywords
GINKGO BILOBA EXTRACT;
PHARMACOLOGICAL BIOMARKER;
PITTSBURGH COMPOUND B;
ALZHEIMER DISEASE;
APOPTOSIS;
ASIA;
AUSTRALIA;
CAENORHABDITIS ELEGANS;
CLINICAL RESEARCH;
CLINICAL STUDY;
CLINICAL TRIAL (TOPIC);
DISEASE COURSE;
DISEASE MARKER;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG SAFETY;
DRUG TOLERABILITY;
EUROPE;
EXPLORATORY RESEARCH;
GINKGO BILOBA;
HUMAN;
LOW DRUG DOSE;
LUMBAR PUNCTURE;
MENTAL PATIENT;
MILD COGNITIVE IMPAIRMENT;
NEUROCHEMISTRY;
NONHUMAN;
NORTH AMERICA;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PATHOPHYSIOLOGY;
PATIENT COMPLIANCE;
POSITRON EMISSION TOMOGRAPHY;
REVIEW;
SINGLE DRUG DOSE;
STATISTICAL ANALYSIS;
ALZHEIMER DISEASE;
BIOLOGICAL MARKERS;
COGNITION DISORDERS;
GINKGO BILOBA;
HUMANS;
PHYTOTHERAPY;
PLANT EXTRACTS;
|
|
EID: 84863953528
PISSN: 10416102
EISSN: 1741203X
Source Type: Journal
DOI: 10.1017/S1041610212001019 Document Type: Review |
|
Times cited : (25)
|
|
References (7)
|
